At 36 weeks, the 12mg dose produced 16.9% body weight reduction in this population, somewhat less than the 24% seen in the general obesity population but still clinically significant
Never mix insulin and GLP-1 agonists in the same syringe unless specifically using a combination product designed for this purpose
The preservative system acts as a critical component of a contamination-control framework
not recommended for use with DPP-4 inhibitors Common side effects : Gastrointestinal symptoms (nausea, vomiting, diarrhea) that typically diminish with continued use and proper dose titration Referral to endocrinology or obesity medicine specialists is appropriate for complex cases, including patients with multiple failed therapies, significant comorbidities, or those requiring comprehensive weight management programs
Licensed online pharmacies may also have Mounjaro and Zepbound in stock, and your doctor may be able to arrange a mail-order prescription for you